Cancer Immunotherapy
Pembrolizumab
BPT-1201 · Intravenous injection
What is it used for?
An antibody that blocks PD-1, helping the immune system recognize cancer cells. Used for selected lung, head and neck, triple-negative breast and other cancers; eligibility depends on cancer type, stage, biomarkers and the treatment combination.
- Dosage form
- Intravenous injection
- Listed strengths
- 100 mg/4 mL
- Listed pack size
- 1's
- Mechanism
- PD-1 immune checkpoint inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Selected non-small-cell lung cancers
- Selected head and neck cancers
- Selected triple-negative breast cancers
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information